Skip to main content
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 2001 Jan;18(1):21–25. doi: 10.1023/A:1026494528415

Soluble CD44 in Human Ovarian Follicular Fluid

N Ohta 1, H Saito 1, T Kaneko 1, M Yoshida 1, T Takahashi 1, T Saito 1, K Nakahara 1, M Hiroi 1
PMCID: PMC3455809  PMID: 11292991

Abstract

Purpose: In the present study, we investigated the existence of soluble CD44 (sCD44) in human follicular fluid, the relationship between the concentration of sCD44 and that of other hormonal parameters, and the prognostic value of sCD44 in follicular fluid in in vitro fertilization (IVF) programs.

Methods: A total of 63 follicular fluid specimens from patients (n=30) participating in our IVF programs was analyzed by RIA and enzyme-linked immunosorbent assay (ELISA).

Results: The mean concentration (±SE) of sCD44 in follicular fluid was 265.4 ± 7.8 ng/ml. The variation of the follicular fluid concentration of sCD44 was strictly associated with that of human chorionic gonadotropin (hCG) (r = 0.572, P < 0.0001). The mean concentration of sCD44 in follicular fluid was significantly higher in follicles containing subsequently unfertilized oocytes than that in those containing oocytes that had undergone fertilization (P = 0.0428). In the analysis of each follicle that contained an oocyte subsequently fertilized, the mean concentration of sCD44 was significantly higher in follicular fluid with the subsequently good-quality embryos than in that with the subsequently poor-quality embryos (P < 0.05).

Conclusions: These results indicated that the concentration of sCD44 in follicular fluid reflects the development of embryos derived from the same follicle, so the sCD44 in human follicular fluid may be useful in the assessment of the prognostic value of IVF programs.

Keywords: follicular fluid, human chorionic gonadotropin, in vitro fertilization, soluble CD44

Full Text

The Full Text of this article is available as a PDF (55.0 KB).

REFERENCES

  • 1.Adashi EY. The potential relevance of cytokines to ovarian physiology: The emerging role of resident ovarian cells of the white blood cell series. Endocr Rev. 1990;11:454–464. doi: 10.1210/edrv-11-3-454. [DOI] [PubMed] [Google Scholar]
  • 2.Mayerhofer A, Lahr G, Gratzl M. Expression of the neural cell adhesion molecule in endocrine cells of the ovary. Endocrinology. 1991;129:792–800. doi: 10.1210/endo-129-2-792. [DOI] [PubMed] [Google Scholar]
  • 3.Fujiwara H, Ueda M, Imai K. Human leukocytes antigen-DR is a differentiation antigen for human granulosa cells. Biol Reprod. 1993;49:705–715. doi: 10.1095/biolreprod49.4.705. [DOI] [PubMed] [Google Scholar]
  • 4.Sy MS, Liu D, Schiavone R, et al. Interactions between CD44 and hyaluronic acid: Their role in tumor growth and metastasis. Curr Topics Microbiol Immunol. 1996;213:129–153. doi: 10.1007/978-3-642-80071-9_9. [DOI] [PubMed] [Google Scholar]
  • 5.Ohta N, Saito H, Kuzumaki T, et al. Expression of CD44 in human cumulus and mural granulosa cells of individual patients in in-vitro fertilization programmes. Mol Hum Reprod. 1999;5:22–28. doi: 10.1093/molehr/5.1.22. [DOI] [PubMed] [Google Scholar]
  • 6.Haynes BF, Hale LP, Patton KL, et al. Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Arthr Rheum. 1991;34:1434–1443. doi: 10.1002/art.1780341115. [DOI] [PubMed] [Google Scholar]
  • 7.Falleti E, Pirisi M, Fabbis C, et al. Circulating standard CD44 isoform in patients with liver disease: Relationship with other soluble adhesion molecules and evaluation of diagnostic usefulness. Clin Biochem. 1997;30:69–73. doi: 10.1016/s0009-9120(96)00135-x. [DOI] [PubMed] [Google Scholar]
  • 8.Guo Y-J, Liu G, Wang X, et al. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res. 1994;54:422–426. [PubMed] [Google Scholar]
  • 9.Ristamaki R, Joensuu H, Hagberg H, et al. Clinical significance of circulating CD44 in non-Hodgkin's lymphoma. Int J Cancer. 1998;79:221–225. doi: 10.1002/(sici)1097-0215(19980619)79:3<221::aid-ijc2>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  • 10.Zeimet AG, Widschwendter M, Uhl-Steidl M, et al. High serum levels of soluble CD44 variant isoforms v5 are associated with favourable clinical outcome in ovarian cancer. Br J Cancer. 1997;76:1646–1651. doi: 10.1038/bjc.1997.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Quinn P, Warnes GM, Kerin JF, et al. Culture factors in relation to the success of human in vitro fertilization and embryo transfer. Fertil Steril. 1984;41:202–209. doi: 10.1016/s0015-0282(16)47591-6. [DOI] [PubMed] [Google Scholar]
  • 12.Saito H, Hiroi M. Correlation between the follicular gonadotropin inhibitor and the maturity of the ovum-corona-cumulus complex. Fertil Steril. 1986;46:66–72. [PubMed] [Google Scholar]
  • 13.Enien WM, Chantler E, Seif MW, et al. Human ovarian granulosa cells and follicular fluid indices: The relationship to oocyte maturity and fertilization in vitro. Hum Reprod. 1998;13:1303–1306. doi: 10.1093/humrep/13.5.1303. [DOI] [PubMed] [Google Scholar]
  • 14.Joaquin A, Lavanya C, Petra V, et al. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J Biol Chem. 1996;271:11376–11382. doi: 10.1074/jbc.271.19.11376. [DOI] [PubMed] [Google Scholar]
  • 15.Jurgen M, Charles T, Rauch MF, et al. Further evidence for a common mechanism for shedding of cell surface proteins. FEBS Lett. 1997;401:235–238. doi: 10.1016/s0014-5793(96)01480-9. [DOI] [PubMed] [Google Scholar]
  • 16.Vladimir B, Vaclav H. Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor ligand. J Immunol. 1992;149:747–753. [PubMed] [Google Scholar]
  • 17.Vladimir B, Jack LS. Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. J Immunol. 1994;152:1314–1322. [PubMed] [Google Scholar]
  • 18.Underhill CB, Green SJ, Comoglio PM, et al. The hyaluronate receptor is identical to a glycoprotein of Mr 85000 (gp85) as shown by a monoclonal antibody that interferes with binding activity. J Biol Chem. 1987;262:13142–13146. [PubMed] [Google Scholar]
  • 19.Sato E, Ishibashi T, Koide SS. Prevention of spontaneous degeneration of mouse oocytes in culture by ovarian glycosaminoglycans. Biol Reprod. 1987;37:371–376. doi: 10.1095/biolreprod37.2.371. [DOI] [PubMed] [Google Scholar]
  • 20.Miyano T, Hirooka RE, Kano K, et al. Effects of hyaluronic acid on the development of 1-and 2-cell porcine embryos to the blastocyst stage in vitro. Theriogenology. 1994;41:1299–1305. doi: 10.1016/0093-691x(94)90488-5. [DOI] [PubMed] [Google Scholar]
  • 21.Kurebayashi S, Miyake M, Katayama M, et al. Improvement of developmental ability to the blastocyst stage by addition of hyaluronic acid to chemically defined medium in diploid porcine eggs matured in-vitro and subsequently electro-activated. J Mamm Ova Res. 1995;12:119–125. [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES